SBFM Q4 2017 Earnings — Sunshine Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

SBFMSunshine Biopharma, Inc.

$6M

Q4 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$33,600-50.7% YoY

Gross Profit

$16,80050.0% margin

Operating Income

-$162,177-482.7% margin

Net Income

-$211,479-629.4% margin

EPS (Diluted)

$-4.49

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$209,482

Free Cash Flow

-$213,200

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$257,485

Total Liabilities

$830,848

Stockholders' Equity

-$573,363

Cash & Equivalents

$107,532

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$33,600	$68,138	-50.7%
Gross Profit	$16,800	$34,069	-50.7%
Operating Income	-$162,177	-$336,097	+51.7%
Net Income	-$211,479	-$1M	+81.2%